AKT1 and neoplasm: Collectively, these metabolic findings and our prior transcriptomic data (Li et al., 2018) support a model in which matrine exerts its anti-tumor effect by normalizing sphingolipid metabolism, thus suppressing the oncogenic S1P-PI3K/AKT signaling axis.